SCHEMBL9805157

SCHEMBL9805157

CNc1ncnc2c(N[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)ncnc12

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 2/20 0.57
▸ TSHR P16473 3/20 0.43
▸ ADORA3 P0DMS8 2/20 0.42
▸ ADORA1 P30542 2/20 0.42
▸ PMP22 Q01453 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ ADORA2A P29274 1/20 0.42
▸ ADORA2B P29275 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ SIGMAR1 Q99720 1/20 0.42
▸ SLC29A1 Q99808 1/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ CA1 P00915 3/20 0.42
▸ CA2 P00918 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9805249 0.86 ADK (0.51) ADKTSHRADORA3ADORA1PMP22
SCHEMBL9805237 0.85 ADK (0.65) ADKADORA3ADORA1ADORA2AADORA2B
SCHEMBL9805553 0.85 ADK (0.65) ADKADORA3ADORA1ADORA2AADORA2B
SCHEMBL29466237 0.85 ADK (0.50) ADKTSHRADORA1MEN1KMT2A
SCHEMBL6039883 0.85 ADK (0.50) ADKTSHRADORA1MEN1KMT2A
SCHEMBL6039895 0.85 ADK (0.50) ADKTSHRADORA1MEN1KMT2A
SCHEMBL9805192 0.85 ADK (0.50) ADKTSHRADORA1MEN1KMT2A
SCHEMBL4874118 0.83 ADK (0.76) ADKTSHRCA1CA2
SCHEMBL9805221 0.80 ADK (0.51) ADKTSHRADORA3ADORA1PMP22
SCHEMBL9805252 0.79 PI4KA (0.43) ADKADORA3ADORA1ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5041542-A Antitumor-anticarcinogenic agents NUCLEIC ACID RESEARCH INSTITUTE (US) 1991-08-20 — — US disclosed
Send feedback